Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
939.3500 2.65 (0.28%)
NSE Nov 07, 2025 13:22 PM
Volume: 436.8K
 

logo
Zydus Lifesciences Ltd.
21 Nov 2019
939.35
0.28%
Business Line
Cadila Healthcare said it has received approval from the US health regulator to market Isosorbide Dinitrate tablets used to prevent attacks of chest p
Zydus Lifesciences Ltd. is trading below all available SMAs
USFDA approves Zydus Cadila's Dinitrate tablets, Desonide Cream
Business Line | 21 Nov 2019 1 more
More from Zydus Lifesciences Ltd.
Recommended
Market trades lower, Cummins India's Q2FY26 net profit grows 39% YoY
Trendlyne Marketwatch | 07 Nov 2025, 01:02PM
The banking boom: Rising profits, and a wave of investor confidence
The Baseline | 06 Nov 2025, 03:07PM
Earnings Call Transcript - Cadila Healthcare
| 14 Feb 2020